Journal of Multiple Sclerosis
ISSN - 2376-0389NLM - 101654564
Maggie Liu
Science Advisor in Government &Regulatory Affairs Practice Group on the Pharmaceutical Team.
Maggie Liu is a senior science advisor in the Government & Regulatory Affairs Practice Group on the Pharmaceutical Team. She supports the pharmaceutical industry collaborative activity that attempts to find solutions to predict, prevent and treat a rare, but life-threatening brain disease - a side effect associated with a variety of immunosuppressive therapies.
Maggie also supports an organization of pharmaceutical and biotechnology companies with a common goal to advance quality and innovation in the development of pharmaceutical products through scientifically driven best practices and standards.
In General. Maggie received her B.S., summa cum laude, in cell biology and genetics from Peking University, Beijing, P.R. China in 2002 and her Ph.D. in biomedical sciences/immunology from Yale University in 2008. She has published research articles in prestigious scientific journals such as Nature, Proceedings of the National Academy of Sciences, and Trends in ImmunologMaggie Liu is a senior science advisor in the Government & Regulatory Affairs Practice Group on the Pharmaceutical Team. She supports the pharmaceutical industry collaborative activity that attempts to find solutions to predict, prevent and treat a rare, but life-threatening brain disease - a side effect associated with a variety of immunosuppressive therapies.
Maggie also supports an organization of pharmaceutical and biotechnology companies with a common goal to advance quality and innovation in the development of pharmaceutical products through scientifically driven best practices and standards.
In General. Maggie received her B.S., summa cum laude, in cell biology and genetics from Peking University, Beijing, P.R. China in 2002 and her Ph.D. in biomedical sciences/immunology from Yale University in 2008. She has published research articles in prestigious scientific journals such as Nature, Proceedings of the National Academy of Sciences, and Trends in Immunology.
She is currently working on Collaborative Approach to Addressing PML.
